Investor profile
Syncona Partners has backed 10 European tech companies across 12 funding rounds between 2014 and 2024, joining rounds totalling €768M. Most active in Healthtech. Data as of 7 Aug 2026.
Also recorded as: Syncona Investment Management · Syncona Limited · Syncona Partners LLP · Syncona Partners LLP.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Quell Therapeutics | UK | 1 | €138M |
| Anaveon | Switzerland | 2 | €136M |
| Freeline Therapeutics | UK | 1 | €107M |
| Neogene Therapeutics | Netherlands | 1 | €93M |
| OMass Therapeutics | UK |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Quell Therapeutics | Series B | €138M | 2021-11 |
| Freeline Therapeutics | Series C | €107M | 2020-07 |
| Anaveon | Series B | €105M | 2021-12 |
| Neogene Therapeutics |
| 1 |
| €90M |
| iOnctura | Switzerland | 1 | €80M |
| Nightstar | UK | 1 | €39M |
| Azeria Therapeutics | UK | 1 | €36M |
| Mosaic Therapeutics | UK | 1 | €25M |
| Cambridge Epigenetix | UK | 2 | €24M |
| Other |
| €93M |
| 2020-09 |
| OMass Therapeutics | Series B | €90M | 2022-04 |
| iOnctura | Series B | €80M | 2024-06 |
| Nightstar | Series C | €39M | 2017-07 |
| Azeria Therapeutics | Series B | €36M | 2019-10 |
| Anaveon | Series A | €31M | 2019-01 |
| Mosaic Therapeutics | Series A | €25M | 2023-04 |
